A Phase 3 interventional study of Povidone-iodine and Saline solution in Surgical Site Infection, sponsored by Hospital de Clinicas de Porto Alegre. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-08.
Sponsored by Hospital de Clinicas de Porto Alegre · Phase 3, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies testing Povidone-Iodine in Surgical Wound Infection — 4 open to participants now, 5 under way, 2 of them phase 3. Povidone-Iodine · Surgical Wound Infection.
Among the 18 studies testing Povidone-Iodine in Surgical Wound Infection, this one is the 9th largest by planned enrollment, is the only one that started in 2023, is one of 3 in phase 3, and was the 15th registered.
747 studies on the registry are indexed under Surgical Wound Infection; 152 are open to participants now.
Browse Surgical Wound Infection studies →4 of the 18 studies testing Povidone-Iodine in Surgical Wound Infection are open now, in 4 countries. Recruiting first, the newest first:
Loma Linda University · Sites in United States
Ages 18–80
National Cheng-Kung University Hospital · Sites in Taiwan
Ages 18+
Mohamed Mousa Mohamed Mousa · Sites in Egypt
Women only · Healthy volunteers
By country, each count listing its studies:
Povidone-Iodine: first FDA approval 1985 (E-Z SCRUB 201). What it is approved for, and how studies give it, is on its page →
Of the 85 Surgical Wound Infection studies recruiting now, 62 (73%) set no upper age limit and 16 (19%) stop at 75 or younger; 12 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 4 · Phase 4 6
First in 2011; this study’s year is marked. 1 started in 2023.
This study's planned enrollment of 228 is above the median of 200 across 583 interventional studies indexed under Surgical Wound Infection.
Median enrollment 210 across the 18 interventional studies. Of the 10 that completed or were terminated, 6 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 18 have an industry lead sponsor. The 10 most frequent:
Hospital de Clinicas de Porto Alegre is the lead sponsor of 456 studies on the registry; 61 are open to participants now.
Hospital de Clinicas de Porto Alegre has 2 studies filed under Surgical Wound Infection — fewer than ten, so there is no comparison to draw.
1 of the studies testing Povidone-Iodine in Surgical Wound Infection that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07715409Mohamed Mousa Mohamed MousaEffect of Betadine Vaginal Cleansing Before Cesarean Section to Reduce Postoperative Infectious Morbidity | 2027-05-01 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies testing Povidone-Iodine in Surgical Wound Infection, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Considering the relatively high incidence of surgical site infection (SSI) in colorectal surgery, this trial will compare rates of SSI in patients undergoing colorectal resections followed by surgical wound irrigation with povidone-iodine versus the group of patients undergoing surgical wound irrigation with saline solution. The trial will be conducted in a large university hospital in Southern Brazil.
Patients will be randomized to one of the following intervention groups:
Group 1: intraoperative irrigation/washing of the surgical incision with povidone-iodine (PVP-I); Detail: after aponeurotic synthesis and immediately before cutaneous synthesis, the skin and subcutaneous tissue of the surgical incision will be irrigated and washed abundantly with approximately 500ml (depending on the size of the incision) of povidone-iodine solution (PVP-I). The exact volume to be used will be the minimum volume necessary for abundant and efficient washing of the incision tissues. " Group 2: intraoperative irrigation/washing of the surgical incision with saline solution (NaCl 0.9%); Detail: after aponeurotic synthesis and immediately before cutaneous synthesis, the skin and subcutaneous tissue of the surgical incision will be irrigated and washed abundantly with approximately 500ml (depending on the size of the incision) of saline solution (NaCl 0.9%). The exact volume to be used will be the minimum volume necessary for abundant and efficient washing of the incision tissues.
NOTE: other care routines for participating patients will not be changed by this study. Patients will receive mechanical colon preparation and antibiotic prophylaxis according to routines already in place by the assistant team.
Randomization: the block randomization method will be used (blocks of 4 patients each).
Groups 1 and 2 will be compared with each other regarding the outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients older than 18 years of age diagnosed with benign or malignant colorectal diseases undergoing elective open or video-assisted colectomy or proctectomy (resection) at the Hospital de Clinicas de Porto Alegre - Division of Coloproctology.
Exclusion Criteria:
Patients submitted to colorectal resections using Povidone-iodine in the surgical wound.
Drug: Povidone-iodine
Patients submitted to colorectal resections using saline solution in the surgical wound.
Drug: Saline solution
Application of Povidone-iodine to the surgical wound of patients submitted to colorectal resections.
Application of saline solution to the surgical wound of patients submitted to colorectal resections.
Surgical site infection
Surgical site infection within 30 days from the surgical procedure
Time frame: 30 days
Intracavitary surgical infection
Infections within the abdominal cavity
Time frame: 30 days
Started Jan 2023 (actual). Primary completion is estimated for Dec 2027, 59 months after the start.
Of 38 phase 3 interventional studies under Surgical Wound Infection, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 51. This study's planned 59 months is above that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Povidone-Iodine
Hospital de Clinicas de Porto Alegre →